Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Biologics : Targets & Therapy|August 27, 2009
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)Marco Montillo, Francesca Ricci, Sara Miqueleiz, et al.
Oncotargets and Therapy|February 4, 2011
The spectrum of use of rituximab in chronic lymphocytic leukemiaAlessandra Tedeschi, Eleonora Vismara, Francesca Ricci, et al.
Open Research Europe|October 2, 2023
Predicting acceptance and adoption of renewable energy community solutions: the prosumer psychologyFrancois Brambati, Daniele Ruscio, Federica Biassoni, et al.
Biologics : Targets & Therapy|October 2, 2015
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemiaAnna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Waldenstrom's Macroglobulinemia: An UpdateMaddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Fludarabine-based combination therapies for Waldenström's macroglobulinemiaAlessandra Tedeschi, Sara Miqueleiz Alamos, Francesca Ricci, et al.
Cancer Genetics and Cytogenetics|January 29, 2003
Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. a study of 40 early-onset patientsLuisa Doneda, Marco Montillo, Liliana Intropido, et al.
Haematologica|March 17, 2004
High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantationRoberto Cairoli, Giovanni Grillo, Alessandra Tedeschi, et al.
Future Oncology (London, England)|May 30, 2019
Duvelisib: a new phosphoinositide-3-kinase inhibitor in chronic lymphocytic leukemiaAnna M Frustaci, Alessandra Tedeschi, Marina Deodato, et al.
Pageof 17